• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.44% Nasdaq Up 0.01%

    CytRx Corporation (CYTR)

    -NasdaqCM
    2.88 Up 0.04(1.23%) 2:09PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.84
    Open:2.85
    Bid:2.88 x 1200
    Ask:2.89 x 3000
    1y Target Est:8.50
    Beta:3.46
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:2.81 - 2.92
    52wk Range:2.08 - 5.42
    Volume:494,244
    Avg Vol (3m):1,008,930
    Market Cap:186.94M
    P/E (ttm):N/A
    EPS (ttm):-0.94
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTR

    Comparison

    Symbol% ChgMkt Cap
    CYTRUp 1.23%186.94M
    LLYDown 0.81%90.00B
    NVSUp 0.72%250.04B
    SNYDown 0.06%140.63B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,582.50
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.11
    Quarterly EPS Est (Jun-15) :-0.27
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate is aldoxorubicin, which is in Phase III clinical trial as a therapy for patients with soft tissue sar... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback